Teladoc Health, Inc. (TDOC): Price and Financial Metrics
Teladoc Health, Inc. (TDOC)
Today's Latest Price: $164.16 USD
Updated Mar 27 12:00am
Add TDOC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 66 in Medical - Services
See all "A" rated Strong Buy stocks
TDOC Stock Summary
- TDOC has a higher market value than 89.58% of US stocks; more precisely, its current market capitalization is $11,828,806,710.
- The price/operating cash flow metric for Teladoc Health Inc is higher than 99.64% of stocks in our set with a positive cash flow.
- TDOC's price/sales ratio is 21.38; that's higher than the P/S ratio of 95.18% of US stocks.
- If you're looking for stocks that are quantitatively similar to Teladoc Health Inc, a group of peers worth examining would be EXAS, BL, CVLT, CDLX, and ZS.
- Visit TDOC's SEC page to see the company's official filings. To visit the company's web site, go to www.teladochealth.com.
TDOC Stock Price Chart More Charts
TDOC Price/Volume Stats
| Current price | $164.16 | 52-week high | $176.40 |
| Prev. close | $159.50 | 52-week low | $48.57 |
| Day low | $156.00 | Volume | 3,862,300 |
| Day high | $170.98 | Avg. volume | 2,874,773 |
| 50-day MA | $120.24 | Dividend yield | N/A |
| 200-day MA | $83.58 | Market Cap | 11.98B |
Teladoc Health, Inc. (TDOC) Company Bio
Teladoc Health provides telehealth services via mobile devices, the Internet, video, and phone to clients and their customers in the United States. The company was founded in 2002 and is based in Dallas, Texas.
TDOC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $164.16 | $129532.68 | 81112% |
We started the process of determining a valid price forecast for Teladoc Health Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Teladoc Health Inc ranked in the 100th percentile in terms of potential gain offered. As the table below shows, the model suggests the stock is dramatically undervalued -- investors should note, though, that such returns are always unlikely and not to be expected. In terms of the factors that were most noteworthy in this DCF analysis for TDOC, they are:
- In the past 0.58 years, Teladoc Health Inc has a compound free cash flow growth rate of 7.55%; that's better than 97.63% of cash flow producing equities in the Technology sector, where it is classified.
- The business' balance sheet suggests that 4% of the company's capital is sourced from debt; this is greater than only 11.75% of the free cash flow producing stocks we're observing.
- Teladoc Health Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.77. This coverage rate is greater than that of only 10.32% of stocks we're observing for the purpose of forecasting via discounted cash flows.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | 79519% |
| 1% | 80316% |
| 2% | 81112% |
| 3% | 81908% |
| 4% | 82704% |
| 5% | 83500% |
For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as TDOC, try PRSP, QCCO, ASX, SGMA, and SCWX.
Loading social stream, please wait...